Press Releases

Hogan Lovells admits eight new firms to its Global FinTech Mentor and Momentum Programme

London, 23 September 2020 – International law firm Hogan Lovells is delighted to announce the admission of eight new companies to its Global FinTech Mentor and Momentum Programme for...

Press Releases

Hogan Lovells receives Mansfield Rule 3.0 certification for exceeding key diversity and inclusion standards

Washington, D.C., 22 September 2020 – International law firm Hogan Lovells is pleased to announce that the firm has achieved Mansfield Certification 3.0 for 2020, just two years after ...

Press Releases

Hogan Lovells advises Deutsche Bank AG on a scrip dividend of LEG Immobilien AG

Led by Frankfurt-based partner Michael Schlitt, international law firm Hogan Lovells advised Deutsche Bank AG on the payment of a scrip dividend and the related rights issue by LEG...

Press Releases

Hogan Lovells advises Arm in US$40 billion sale to NVIDIA

Hogan Lovells is advising Arm Limited (Arm), the UK-headquartered multinational semiconductor and software design company of SoftBank Group Corp. and SoftBank Vision Fund, in the US$40...

Awards and Rankings

Hogan Lovells lawyers recognized as 2021 Arbitration Thought Leaders and Future Leaders

Who’s Who Legal (WWL), in association with Global Arbitration Review (GAR), has recognized 14 Hogan Lovells lawyers globally in its “Arbitration 2021” guide.

Awards and Rankings

Hogan Lovells named by Stonewall among the world's top LGBT employers

Washington D.C.,  21 September 2020 – Hogan Lovells is pleased to announce that the firm has been recognized in Stonewall's Top Global Employers 2020, one of only 17...

Awards and Rankings

Three Silicon Valley M&A partners receive 2020 “Top 100” Daily Journal recognition

Hogan Lovells boasts more “Top 100” corporate lawyers than any other law firm.

Press Releases

Eli Lilly secures major win in its long-running patent dispute with Fresenius Kabi over oncology drug Alimta

London, Paris, 16 September 2020 –  Eli Lilly has secured a major win in its long-running patent dispute with Fresenius Kabi over oncology drug Alimta. Eli Lilly was represented...

Loading data